Article
Cover
RJPS Journal Cover Page

RJPS Vol No: 14 Issue No: 3 eISSN: pISSN:2249-2208

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Original Article
Pramodini K N*,1, Paul Richards M2, B A Vishwanath3,

1Pramodini K N, M Pharm, Department of Quality Assurance, Aditya Bangalore Institute of Pharmacy Education and Research, Kogilu, Yelahanka, Bangalore, Karnataka.

2Department of Pharmaceutical Analysis, Aditya Bangalore Institute of Pharmacy Education and Research, Kogilu, Yelahanka, Bangalore, Karnataka.

3Aditya Bangalore Institute of Pharmacy Education and Research, Kogilu, Yelahanka, Bangalore, Karnataka.

*Corresponding Author:

Pramodini K N, M Pharm, Department of Quality Assurance, Aditya Bangalore Institute of Pharmacy Education and Research, Kogilu, Yelahanka, Bangalore, Karnataka., Email: pramodinikn9@gmail.com
Received Date: 2022-10-29,
Accepted Date: 2022-12-08,
Published Date: 2023-03-31
Year: 2023, Volume: 13, Issue: 1, Page no. 1-8, DOI: 10.26463/rjps.13_1_5
Views: 786, Downloads: 26
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Background: Amoxicillin and dicloxacillin are the antibiotics useful for the treatment of a number of bacterial infections constituting the first line of treatment for middle ear infections. It may also be used for Strep throat, pneumonia, skin infections and urinary tract infections. They are taken by mouth or less commonly in injection form.

Objective: The main objective of the simultaneous estimation of Amoxicillin and Dicloxacillin was to establish identity, purity, physical characteristics, and potency of the drugs.

Methodology: The estimation of Amoxicillin and Dicloxacillin was done by Reversed-phase- High performance liquid chromatography (RP-HPLC). The phosphate buffer had a pH of 4.6 and the mobile phase was optimized consisting of Methanol: Phosphate buffer mixed in the ratio of 70:30 %v/v. A Symmetry C18 (4.6 x 150 mm, 5 mm, Make XTerra) column was used as stationary phase.

Results: The results were in good agreement with those obtained with official HPLC with maximum absorption using mobile phase which was optimized consisting of Methonol:Phosphate buffer mixed in the ratio of 70:30 %v/v. A Symmetry C18 (4.6 x 150 mm, 5 mm, Make XTerra) column was used as stationary phase. According to ICH guidelines, all the data were achieved with good precision, accuracy, and robustness.

Conclusion: On the basis of results of assay and validation parameters, it can be concluded that the proposed method was simple, fast, accurate, and precise. It is possible to estimate Amoxicillin and Dicloxacillin dosage forms simultaneously in a combination capsule dosage form that can be used on a regular basis.

<p><strong>Background: </strong>Amoxicillin and dicloxacillin are the antibiotics useful for the treatment of a number of bacterial infections constituting the first line of treatment for middle ear infections. It may also be used for Strep throat, pneumonia, skin infections and urinary tract infections. They are taken by mouth or less commonly in injection form.</p> <p><strong>Objective: </strong>The main objective of the simultaneous estimation of Amoxicillin and Dicloxacillin was to establish identity, purity, physical characteristics, and potency of the drugs.</p> <p><strong>Methodology: </strong>The estimation of Amoxicillin and Dicloxacillin was done by Reversed-phase- High performance liquid chromatography (RP-HPLC). The phosphate buffer had a pH of 4.6 and the mobile phase was optimized consisting of Methanol: Phosphate buffer mixed in the ratio of 70:30 %v/v. A Symmetry C18 (4.6 x 150 mm, 5 mm, Make XTerra) column was used as stationary phase.</p> <p><strong>Results: </strong>The results were in good agreement with those obtained with official HPLC with maximum absorption using mobile phase which was optimized consisting of Methonol:Phosphate buffer mixed in the ratio of 70:30 %v/v. A Symmetry C18 (4.6 x 150 mm, 5 mm, Make XTerra) column was used as stationary phase. According to ICH guidelines, all the data were achieved with good precision, accuracy, and robustness.</p> <p><strong>Conclusion:</strong> On the basis of results of assay and validation parameters, it can be concluded that the proposed method was simple, fast, accurate, and precise. It is possible to estimate Amoxicillin and Dicloxacillin dosage forms simultaneously in a combination capsule dosage form that can be used on a regular basis.</p>
Keywords
Symmetry C18, Amoxicillin, Dicloxacillin, RP-HPLC
Downloads
  • 1
    FullTextPDF
Article
Introduction

A moderate spectrum bacteriolytic antibiotic called amoxicillin is used to treat bacterial infections brought on by susceptible microorganisms. Because it is better absorbed after oral administration, it is typically the medicine of choice within the class. Amoxicillin works by preventing the bacterial cell wall from being produced. It is soluble in water, methanol, and ethanol, but very marginally soluble in toluene.1-4

Materials and Methods

Chemicals and Reagents

Concept Pharmaceuticals Ltd. (Aurangabad, India), provided the Amoxicillin and Dicloxacillin which were utilized as a working standard. Gift sample was given to carried out the analysis for a quantitative analysis, Flumox® Capsules were employed. Analytical grade potassium dihydrogen orthophosphate was used. The High-performance liquid chromatography (HPLC) grade acetonitrile, methanol, and water were acquired from Merck Chem Ltd., Mumbai. For HPLC, all solutions were made with double-distilled R.O. water.5-6

Instrumentation

The HPLC system model Waters 2695 Empower Waters

UV double beam UV 3000

Digital weighing machine

pH meter

Ultra Suction pump.7

Chromatographic Conditions

The estimation of Amoxicillin and Dicloxacillin was done by RP-HPLC. The Phosphate buffer had a pH of 4.6 and the mobile phase was optimized consisting of Methonol:Phosphate buffer mixed in the ratio of 70:30 %v/v. A Symmetry C18 (4.6 x 150 mm, 5 µm, Make XTerra) column was used as stationary phase. The detection was carried out using UV detector at 273 nm. The solutions were chromatographed at a constant flow rate of 1.0 mL/min.8-9

Preparation of Mobile Phase

To establish a relevant HPLC method, couple of different mobile phases were attempted which were decided based on the readily available solvents, short run time, results and sensitivity of assay. Aqueous solvent, or MilliQ water, and an organic solvent, methanol, were determined to be the mobile phases for this experiment. Separate solvents were filtered via 0.45 m membrane filters and sonicated to remove any gas.10

Preparation of Sample Solution

A 10 mL clean, dry volumetric flask was filled with precisely weighed tablet powder containing 8 mg of Amoxicillin and 12.5 mg of Dicloxacillin. About 7 mL of diluent was added, sonicated to completely dissolve, and then volume was adjusted to the required amount using the same solvent (Stock solution). Further, 0.6 mL of the above stock solution was pipetted into a 10 mL volumetric flask and diluted up to the mark with diluent.11

Preparation of Standard Solution

Accurately measured 10 mg of the standard medication Amoxicillin and Dicloxacillin were dissolved in 10 mL of methanol with 1000 g/mL of each antibiotic, individually. It was fully dissolved using sonication. A membrane filter paper was used to further refine it. By using the appropriate dilution, this standard stock solution was utilized to prepare the concentrations required to generate the calibration curve.12

Results

The overlay spectra are shown in Figures 1, 2, 3

Trial 1

Mp              :        Water:Methanol (50:50 %v/v)

Column       :       Thermosil C.18 (4.6*150 mm) 5 µm

Fr                :        1.0 mL/min

Wl               :        260 nm

Ct                :        Ambient

St                :        Ambient

Iv                :        10 µL   

Chromatogram for Amoxicillin and Dicloxacillin

The given chromatogram in Figure no 4 shows that peaks are well separated.3

Retention time of Amoxicillin – 2.003 min

Retention time of Dicloxacillin - 5.067 min

Optimized chromatogram was obtained with the following conditions

Column             :            Symmetry C.18 (4.6 x 150 mm, 5 µm, Make: Xterra) or equivalent

Buffer pH          :            4.6

Mp                    :            70% Methonol: 30% pb ph-4.6

Fr                      :            1 mL per min

Wl                     :            273 nm

Temperature     :            ambient

Rt                      :            7 min

Acceptance criteria (Table 2)

  • Resolution between two drugs allows a resolution of 1.5 to be achieved with about not more than 2000 theoretical plates and tailing issue should not be but 9.

It was found that information obtained of quality parameters for developed methodology was within the limits.

Acceptance criteria(Table 3)

  • % Relative Standard Deviation (RSD) of five completely different sample solutions should not two.
  • The % RSD obtained was within the limit, thus the strategy was rugged.

Acceptance criteria (Table 4)

  • The percentage recovery at every level ought to be between 97-103%.
  • The results obtained for recovery at five hundredth, 100%, a hundred and fiftieth area unit were inside the boundaries. Thus, the strategy was correct.

Linearity (Table 5)

The dimensionality variation was found to lie between twenty fifth to one hundred and twenty fifth and the chromatograms square measure is shown below.

Area of different concentrations of Amoxicillin and Dicloxacillin

Analytical performance parameters of Amoxicillin and Dicloxacillin 

Acceptance criteria (Table 6)

  • Correlation coefficient (R2) should not be but 0.999.
  • The correlation obtained was 0.999 which is within the acceptance limit. The one-dimensionality was established within the variation of twenty-five to 150 µg/mL

Limit of Detection (LOD) of Amoxicillin and Dicloxacillin

With reference to the overall noise, the’ lowest concentration of sample was prepared, and the quantitative signal to noise relationship was assessed.

Limit of Quantitation (LOQ) of Amoxicillin and Dicloxacillin

The lowest concentration of the sample was prepared with respect to the whole noise, and the quantitative signal to noise relationship was assessed.

Acceptance criteria (Table 7)

  • Signal to noise magnitude relation ought to be three for LOD resolution.
  • The results obtained were inside the limit.

Acceptance criteria (Table 8)

  • Signal to noise quantitative relation ought to be ten for LOQ resolution.
  • The results obtained were within limits.

Results of Robustness (Table 9)

  • The standard sample and samples of Augmentin and antibacterial were injected by continuously changing the conditions of activity. There was no important modification observed within the parameters like resolution, tailing issue, uneven issue, and plate count.
  • The degree of test result repeatability was determined under a range of standard testing circumstances, including different labs, analysts, instruments, reagent lots, elapsed assay periods, assay temperatures, different days etc, unaffected by small but deliberate variations in method parameters.
  • Adequate method development - separation on column described in method was uniform and no column deterioration was observed.
  • Resolution of the critical pair of peaks in the chromatogram.

Acceptance criteria for variation in flow (Table 10)

  • Percentage RSD must not be two.
  • The %RSD obtained for flow of rate, variation in mobile phase was found to be below two, that is at five intervals the acceptance criteria. Hence the method is accepted .
Discussion

Method Development

Selection of Detection wavelength

Bactericide and Larotid 10 mg were dissolved in the mobile component. The spectra of the solution were obtained and scanned from 200 to 400 nm. The wavelength for Larotid and the bactericide was selected using the overlay spectrum. The detecting wavelength was chosen to be the isobestic purpose.13-14

Validation Parameters

Precision

Precision of the strategy was administered for each sample and the customary solutions as delineated beneath experimental work. The corresponding chromatograms and results are shown below.

System Suitability

The system suitability of the strategy was checked by injecting five completely different preparations of the Larotid and its antibacterial effect. The parameters of system suitability were checked.

Intermediate Precession (Ruggedness)

At completely different levels of huskiness, such as day-to-day and system-to-system variation, there was no significant change in the assay content and system quality metrics.

Accuracy

Sample solutions at totally different concentrations (50%, 100% & 150%) were ready and also the recovery was calculated.

Conclusion

Based on the assay results and validation parameters, it was determined that the proposed method for the simultaneous estimation of Amoxicillin and Dicloxacillin in combined capsule dosage form was straightforward, quick, accurate, and precise. It can also be used for the routine estimation of Amoxicillin and Dicloxacillin dosage form.

Consent and ethical approval

It is not applicable

Conflict of interest

None

Acknowledgements

We gratefully acknowledge ABIPER and RGUHS University for providing all needed things to prepare this manuscript.

 

Supporting File
References
  1. Ahmed M. Development and validation of amoxicillin by RP-HPLC method in bulk drug and pharmaceutical dosage forms. Int J Chemtech Res 2011;3:1037-1041.
  2. Anil C. RP-HPLC method for simultaneous estimation of amoxicillin and carbocisteine in dosage forms. Der Pharm Lett 2013;5(1):327-333.
  3. Giang DT, Hoang VD. Comparative study of RPHPLC and UV spectrophotometric techniques for the simultaneous determination of amoxicillin and cloxacillin in capsules. J Young Pharm 2010;2(2):190-195.
  4. Batrawi N, Wahdan S, Al-Rimawi F. A validated stability-indicating HPLC method for simultaneous determination of amoxicillin and enrofloxacin combination in an injectable suspension. Sci Pharm 2017;85(1):6.
  5. Sonawane LV, Bari SB. Development and validation of RP-HPLC method for the simultaneous estimation of amoxicillin trihydrate and bromhexine hydrochloride from oily suspension. Pharm Anal Acta 2010;1:107.
  6. Gauhar S, Ali SA, Shoaib H, Baqir S, Naqvi S, Development and validation of a HPLC method for determination of pefloxacin in tablet and human plasma. Iranian J Basic Med Sci 2009;(12):33-42.
  7. Almeida AA, Campos DR, Calafatti S, Meurera EC. Determination of memantine in human plasma by liquid chromatography electrospray tandem mass spectrometry: Application to a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci 2007;848:311-316.
  8. Harada T, Iwamori M, Nagai Y, Nomura Y. Analysis of aminoglycoside antibiotics as benzoyl derivatives by HPLC and its application to the quantitation of neomycin in the perilymph. J Chromatogr B Biomed Appl 1985;337:187-193.
  9. ICH Steering Committee, ICH Q2B Validation of Analytical Procedures: methodology, European Agency for the Evaluation of Medicinal Products, International Commission on Harmonisation, London (CPMP/ICH/281/ 95), 1996. Available at: http://www.ich.org/ .
  10. International Conference on Harmonazation (ICH Q2A), Text on validation of analytical procedures, 1995;1-9.
  11. ICH guidelines for validation of analytical procedures: text and methodology. Q2 (R1) ICH, Geneva 2005; 1-14.
  12. Ravisankar P, Anusha S, Supriya K, Kumar UA. Fundamental chromatographic parameters. Int J Pharm Sci Rev Res 2019;55:46-50.
  13. Snyder LR, Kirkland J, Dolan JW. Introduction to modern liquid chromatography. 3rd edition. New Jersey: John Wiley & Sons Inc.; 2010. p. 65-69. 14. Bliesner DM. Validating chromatographic methods, a practical guide. New York: John Wiley & Sons Inc.; 2006. p. 8-14.
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.